Physician profile
Stephen Schaffer
NPI 1720051089
$1,801.30
in general payments reported to CMS, 2019-2025
11 companies · $236 in 2025
The $236 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $116 · 2021: $549 · 2022: $294 · 2023: $209 · 2024: $257 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597 · Consulting Fee: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $597.18 |
| Consulting Fee | $105.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $585.83 | 2019-2022 | |
| Genzyme Corporation | $272.46 | 2020-2025 | |
| Stryker Corporation | $226.95 | 2021-2023 | Clarifix Cryotherapy Device, Xpress Ent Dilation System, Nasopore |
| Glaxosmithkline, LLC. | $226.87 | 2022-2025 | Nucala |
| Medtronic, INC. | $196.50 | 2022-2023 | Nuvent, Propel |
| Adma Biomanufacturing LLC | $105.01 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $53.37 | 2020-2024 | Dupixent |
| Aerin Medical INC. | $42.24 | 2025 | |
| Integra Lifesciences Corporation | $39.83 | 2024 | Inspira Air, Acclarent Aera, Trudi Probe |
| Smith+Nephew, INC. | $30.86 | 2024 | Na, N/A |
| Inspire Medical Systems, INC. | $21.38 | 2023 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Schaffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.